nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.113	0.143	CbGbCtD
Sulfasalazine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0784	0.0989	CbGbCtD
Sulfasalazine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0582	0.0735	CbGbCtD
Sulfasalazine—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0534	0.0674	CbGbCtD
Sulfasalazine—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0498	0.0628	CbGbCtD
Sulfasalazine—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0492	0.0621	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0489	0.0617	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0483	0.061	CbGbCtD
Sulfasalazine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0483	0.0609	CbGbCtD
Sulfasalazine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.045	0.0568	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0442	0.0558	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0408	0.0515	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0334	0.0421	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0302	0.0381	CbGbCtD
Sulfasalazine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0267	0.0337	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0245	0.0309	CbGbCtD
Sulfasalazine—SLC7A11—forelimb zeugopod—peripheral nervous system neoplasm	0.0161	0.354	CbGeAlD
Sulfasalazine—TBXAS1—forelimb—peripheral nervous system neoplasm	0.011	0.243	CbGeAlD
Sulfasalazine—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00444	0.728	CbGdCrCtD
Sulfasalazine—SLC7A11—tongue—peripheral nervous system neoplasm	0.00433	0.0952	CbGeAlD
Sulfasalazine—PPARG—forelimb—peripheral nervous system neoplasm	0.00416	0.0915	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00166	0.273	CbGdCrCtD
Sulfasalazine—ACAT1—cerebellum—peripheral nervous system neoplasm	0.00153	0.0336	CbGeAlD
Sulfasalazine—PTGS1—ganglion—peripheral nervous system neoplasm	0.0012	0.0264	CbGeAlD
Sulfasalazine—SLC46A1—cerebellum—peripheral nervous system neoplasm	0.00114	0.025	CbGeAlD
Sulfasalazine—CHUK—cerebellum—peripheral nervous system neoplasm	0.00114	0.025	CbGeAlD
Sulfasalazine—SLC7A11—cerebellum—peripheral nervous system neoplasm	0.000938	0.0206	CbGeAlD
Sulfasalazine—IKBKB—cerebellum—peripheral nervous system neoplasm	0.000775	0.017	CbGeAlD
Sulfasalazine—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000708	0.0156	CbGeAlD
Sulfasalazine—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000668	0.0147	CbGeAlD
Sulfasalazine—ALOX5—cerebellum—peripheral nervous system neoplasm	0.000642	0.0141	CbGeAlD
Sulfasalazine—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.000564	0.0124	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000309	0.00679	CbGeAlD
Sulfasalazine—PTGS2—cerebellum—peripheral nervous system neoplasm	0.000246	0.00541	CbGeAlD
Sulfasalazine—IKBKB—Immune System—PPP3R1—peripheral nervous system neoplasm	7.36e-05	0.000471	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.35e-05	0.000471	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	7.31e-05	0.000468	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.26e-05	0.000465	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	7.26e-05	0.000465	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	7.21e-05	0.000462	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.19e-05	0.00046	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NCAM1—peripheral nervous system neoplasm	7.17e-05	0.000459	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	7.09e-05	0.000454	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	7.07e-05	0.000452	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—NRAS—peripheral nervous system neoplasm	7.06e-05	0.000452	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	6.97e-05	0.000446	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	6.95e-05	0.000445	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	6.94e-05	0.000445	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.9e-05	0.000442	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—CASP3—peripheral nervous system neoplasm	6.84e-05	0.000438	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	6.83e-05	0.000438	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.8e-05	0.000435	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—ERBB2—peripheral nervous system neoplasm	6.72e-05	0.00043	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.72e-05	0.00043	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	6.69e-05	0.000429	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	6.68e-05	0.000428	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	6.64e-05	0.000425	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	6.62e-05	0.000424	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	6.61e-05	0.000423	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	6.6e-05	0.000422	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.59e-05	0.000422	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	6.58e-05	0.000422	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	6.58e-05	0.000421	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	6.56e-05	0.00042	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HRAS—peripheral nervous system neoplasm	6.54e-05	0.000419	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	6.52e-05	0.000418	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.52e-05	0.000417	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NCAM1—peripheral nervous system neoplasm	6.5e-05	0.000416	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ENO2—peripheral nervous system neoplasm	6.49e-05	0.000415	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	6.45e-05	0.000413	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	6.43e-05	0.000412	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	6.42e-05	0.000411	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	6.42e-05	0.000411	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	6.41e-05	0.000411	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—GNS—peripheral nervous system neoplasm	6.34e-05	0.000406	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.31e-05	0.000404	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	6.24e-05	0.0004	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—CASP3—peripheral nervous system neoplasm	6.2e-05	0.000397	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.19e-05	0.000397	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.19e-05	0.000397	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	6.18e-05	0.000395	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.17e-05	0.000395	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.17e-05	0.000395	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	6.16e-05	0.000394	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	6.16e-05	0.000394	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—peripheral nervous system neoplasm	6.16e-05	0.000394	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	6.14e-05	0.000393	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.11e-05	0.000391	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	6.1e-05	0.000391	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	6.09e-05	0.00039	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GNAS—peripheral nervous system neoplasm	6.06e-05	0.000388	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.06e-05	0.000388	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—peripheral nervous system neoplasm	6.05e-05	0.000388	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	6.05e-05	0.000387	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	6.02e-05	0.000386	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	5.98e-05	0.000383	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—peripheral nervous system neoplasm	5.96e-05	0.000381	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.95e-05	0.000381	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	5.86e-05	0.000376	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	5.85e-05	0.000374	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.84e-05	0.000374	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	5.84e-05	0.000374	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	5.83e-05	0.000373	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	5.81e-05	0.000372	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	5.81e-05	0.000372	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	5.79e-05	0.000371	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—AKT1—peripheral nervous system neoplasm	5.78e-05	0.00037	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.73e-05	0.000367	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—NRAS—peripheral nervous system neoplasm	5.73e-05	0.000367	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—peripheral nervous system neoplasm	5.7e-05	0.000365	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—peripheral nervous system neoplasm	5.7e-05	0.000365	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	5.7e-05	0.000365	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.68e-05	0.000364	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNB1—peripheral nervous system neoplasm	5.62e-05	0.00036	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.6e-05	0.000358	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	5.58e-05	0.000357	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	5.45e-05	0.000349	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PTPN11—peripheral nervous system neoplasm	5.44e-05	0.000348	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	5.44e-05	0.000348	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—AKT1—peripheral nervous system neoplasm	5.44e-05	0.000348	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	5.44e-05	0.000348	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000345	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—AKT1—peripheral nervous system neoplasm	5.34e-05	0.000342	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	5.34e-05	0.000342	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	5.32e-05	0.00034	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	5.31e-05	0.00034	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	5.29e-05	0.000339	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	5.27e-05	0.000338	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.25e-05	0.000336	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SLC2A1—peripheral nervous system neoplasm	5.23e-05	0.000335	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	5.22e-05	0.000334	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—NRAS—peripheral nervous system neoplasm	5.2e-05	0.000333	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.18e-05	0.000332	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—peripheral nervous system neoplasm	5.17e-05	0.000331	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	5.16e-05	0.000331	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.15e-05	0.00033	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	5.14e-05	0.000329	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.12e-05	0.000328	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NRAS—peripheral nervous system neoplasm	5.11e-05	0.000327	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNB1—peripheral nervous system neoplasm	5.1e-05	0.000327	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	5.09e-05	0.000326	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—peripheral nervous system neoplasm	5.03e-05	0.000322	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—peripheral nervous system neoplasm	5.03e-05	0.000322	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	4.99e-05	0.00032	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PTPN11—peripheral nervous system neoplasm	4.93e-05	0.000316	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	4.93e-05	0.000316	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	4.9e-05	0.000314	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	4.89e-05	0.000313	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	4.81e-05	0.000308	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	4.79e-05	0.000306	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MYC—peripheral nervous system neoplasm	4.76e-05	0.000305	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.76e-05	0.000305	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	4.74e-05	0.000303	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.67e-05	0.000299	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	4.61e-05	0.000295	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—TH—peripheral nervous system neoplasm	4.6e-05	0.000294	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—peripheral nervous system neoplasm	4.56e-05	0.000292	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	4.56e-05	0.000292	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	4.44e-05	0.000284	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.37e-05	0.00028	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HGF—peripheral nervous system neoplasm	4.34e-05	0.000278	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ERBB2—peripheral nervous system neoplasm	4.3e-05	0.000275	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	4.27e-05	0.000273	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	4.22e-05	0.00027	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—peripheral nervous system neoplasm	4.19e-05	0.000269	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—peripheral nervous system neoplasm	4.18e-05	0.000267	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	4.13e-05	0.000264	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	4.05e-05	0.00026	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.94e-05	0.000253	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.94e-05	0.000252	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HGF—peripheral nervous system neoplasm	3.94e-05	0.000252	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.9e-05	0.00025	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ERBB2—peripheral nervous system neoplasm	3.9e-05	0.00025	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	3.87e-05	0.000248	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.85e-05	0.000247	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	3.84e-05	0.000246	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—peripheral nervous system neoplasm	3.8e-05	0.000244	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	3.75e-05	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	3.74e-05	0.00024	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—peripheral nervous system neoplasm	3.74e-05	0.00024	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—peripheral nervous system neoplasm	3.7e-05	0.000237	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	3.68e-05	0.000236	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.67e-05	0.000235	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	3.62e-05	0.000232	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.59e-05	0.00023	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.57e-05	0.000229	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	3.57e-05	0.000228	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	3.43e-05	0.000219	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.4e-05	0.000218	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.37e-05	0.000216	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—peripheral nervous system neoplasm	3.36e-05	0.000215	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	3.35e-05	0.000215	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000212	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NRAS—peripheral nervous system neoplasm	3.27e-05	0.000209	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.27e-05	0.000209	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	3.22e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	3.22e-05	0.000206	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.21e-05	0.000206	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTPN11—peripheral nervous system neoplasm	3.17e-05	0.000203	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—peripheral nervous system neoplasm	3.17e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	3.14e-05	0.000201	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	3.1e-05	0.000198	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.06e-05	0.000196	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.03e-05	0.000194	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	3.02e-05	0.000194	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NRAS—peripheral nervous system neoplasm	2.97e-05	0.00019	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.96e-05	0.000189	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.95e-05	0.000189	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTPN11—peripheral nervous system neoplasm	2.92e-05	0.000187	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.91e-05	0.000186	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.9e-05	0.000186	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.89e-05	0.000185	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTPN11—peripheral nervous system neoplasm	2.87e-05	0.000184	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	2.85e-05	0.000182	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.77e-05	0.000177	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	2.74e-05	0.000175	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	2.72e-05	0.000174	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.69e-05	0.000172	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.67e-05	0.000171	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	2.63e-05	0.000168	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.59e-05	0.000166	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.58e-05	0.000165	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	2.56e-05	0.000164	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	2.56e-05	0.000164	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000163	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ERBB2—peripheral nervous system neoplasm	2.5e-05	0.00016	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.44e-05	0.000156	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	2.4e-05	0.000154	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.39e-05	0.000153	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ERBB2—peripheral nervous system neoplasm	2.31e-05	0.000148	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—peripheral nervous system neoplasm	2.31e-05	0.000148	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.3e-05	0.000147	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERBB2—peripheral nervous system neoplasm	2.27e-05	0.000145	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.17e-05	0.000139	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.11e-05	0.000135	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	2.09e-05	0.000134	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.08e-05	0.000133	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.05e-05	0.000131	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.05e-05	0.000131	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	2.03e-05	0.00013	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.96e-05	0.000126	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.92e-05	0.000123	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.92e-05	0.000123	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—peripheral nervous system neoplasm	1.9e-05	0.000122	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	1.88e-05	0.00012	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000119	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000118	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	1.73e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—peripheral nervous system neoplasm	1.73e-05	0.000111	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—peripheral nervous system neoplasm	1.64e-05	0.000105	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.62e-05	0.000104	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.47e-05	9.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.47e-05	9.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—peripheral nervous system neoplasm	1.39e-05	8.92e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	1.37e-05	8.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.33e-05	8.53e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.3e-05	8.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—peripheral nervous system neoplasm	1.29e-05	8.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—peripheral nervous system neoplasm	1.26e-05	8.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.23e-05	7.88e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—peripheral nervous system neoplasm	1.23e-05	7.88e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.15e-05	7.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—peripheral nervous system neoplasm	1.14e-05	7.27e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.12e-05	7.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—peripheral nervous system neoplasm	1.12e-05	7.14e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.04e-05	6.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.04e-05	6.66e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-05	6.49e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—peripheral nervous system neoplasm	9.7e-06	6.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.42e-06	6.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.01e-06	5.77e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.54e-06	5.47e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.17e-06	5.23e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	7.98e-06	5.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.95e-06	5.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	7.62e-06	4.88e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	7.39e-06	4.73e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.21e-06	4.62e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	7.1e-06	4.54e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	6.73e-06	4.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	5.63e-06	3.61e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	5.29e-06	3.39e-05	CbGpPWpGaD
